Understanding patient experiences with lung cancer screening
CPRIT: Patient Adherence to Lung Cancer Screening
This study is trying to understand what makes it hard for people to get lung cancer screenings and how their experiences with scheduling these screenings can be improved.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 340 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06872723 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify barriers to lung cancer screening and assess patient experiences with scheduling these screenings. It will analyze rates of lung cancer screening at the UTMB and UT Tyler programs and utilize advanced machine learning techniques to create predictive models for adherence to screening guidelines. Participants will be surveyed about their experiences, and interviews will be conducted with those who do not complete their screenings as well as with program directors to identify factors influencing screening rates.
Who should consider this trial
Good fit: Ideal candidates include current smokers or individuals who have quit within the past 15 years with a significant smoking history.
Not a fit: Patients who do not have an order for lung cancer screening or those without a relevant smoking history may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance lung cancer screening rates and improve early detection among at-risk populations.
How similar studies have performed: Other studies have shown success in using predictive modeling and patient feedback to improve screening adherence, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current smoker or quit within the past 15 years * A 20+ pack-year smoking history * Healthy enough for treatment Exclusion Criteria: * Not applicable as our focus is on patients with an order for screening at the UTMB or UT Tyler
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Robert Volk, PHD — M.D. Anderson Cancer Center
- Study coordinator: Robert Volk, PHD
- Email: bvolk@mdanderson.org
- Phone: 713-563-2509
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.